Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Kintor Pharmaceutical Limited KNTPF

Full chart Compare
Set alert

Price alert · KNTPF

All alert types
0.16 USD -0.08 (-35.11%)

At closeNov 2, 2026, 4:00 PM EST

0.5652 Day range 0.5652
0.1542 52-week range 0.5708
YTD
-27.45%
1 year
-41.70%

Financial health

Altman Z-Score

-19.37 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -3.5×
FY 2016: -29.5×FY 2017: -33.4×FY 2018: -16.9×FY 2019: -8.8×FY 2020: -4.9×FY 2021: -29.6×FY 2022: -3.4×FY 2023: -0.5×FY 2024: -3.2×FY 2025: -3.5×
FY 2016 5y median -3.4× FY 2025
P/S 21.3×
FY 2016: 1101×FY 2017: 3165×FY 2018: 2650863×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 727×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 101×FY 2025: 21.3×
FY 2016 5y median 21.3× FY 2025
P/B 3.7×
FY 2016: 95.3×FY 2017: 427×FY 2018: 7352×FY 2019: 5555×FY 2020: 1650×FY 2021: 15.0×FY 2022: 2.2×FY 2023: 1.1×FY 2024: 1.7×FY 2025: 3.7×
FY 2016 5y median 2.2× FY 2025
P/FCF -4.0×
FY 2016: -93525×FY 2017: -27261×FY 2018: -15404×FY 2019: -6955×FY 2020: -5529×FY 2021: -22084×FY 2022: -3257×FY 2023: -1.3×FY 2024: -2.5×FY 2025: -4.0×
FY 2016 5y median -4.0× FY 2025
EV/EBITDA -4.5×
FY 2016: -27.3×FY 2017: -35.6×FY 2018: -18.8×FY 2019: -9.9×FY 2020: -6.9×FY 2021: -30.4×FY 2022: -3.7×FY 2023: -0.3×FY 2024: -3.8×FY 2025: -4.5×
FY 2016 5y median -3.8× FY 2025
EV/Sales 23.0×
FY 2016: 1094×FY 2017: 3230×FY 2018: 2750441×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 732×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 97.7×FY 2025: 23.0×
FY 2016 5y median 23.0× FY 2025
FCF Yield -25.1%
FY 2016: -0.0%FY 2017: -0.0%FY 2018: -0.0%FY 2019: -0.0%FY 2020: -0.0%FY 2021: -0.0%FY 2022: -0.0%FY 2023: -74.5%FY 2024: -39.9%FY 2025: -25.1%
FY 2016 5y median -25.1% FY 2025

Profitability

Gross Margin -77.0%
FY 2016: 74.6%FY 2017: 28.5%FY 2018: 1.3%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 100.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -94.6%FY 2025: -77.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin -619.9%
FY 2016: -4039.4%FY 2017: -9407.1%FY 2018: -15706.9%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -2452.8%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -2891.4%FY 2025: -619.9%
FY 2016 5y median -619.9% FY 2025
Net Margin -612.3%
FY 2016: -3718.3%FY 2017: -9433.5%FY 2018: -15542.1%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -2460.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -3105.8%FY 2025: -612.3%
FY 2016 5y median -612.3% FY 2025
ROE -106.7%
FY 2016: -321.8%FY 2017: -1272.9%FY 2018: -43.1%FY 2019: -62915.8%FY 2020: -33708.4%FY 2021: -50.9%FY 2022: -63.8%FY 2023: -231.6%FY 2024: -52.8%FY 2025: -106.7%
FY 2016 5y median -63.8% FY 2025
ROIC -65.1%
FY 2016: -349.6%FY 2017: -94.8%FY 2018: 0.1%FY 2019: -351.1%FY 2020: -28.5%FY 2021: 403.2%FY 2022: -51.3%FY 2023: -18.9%FY 2024: -31.3%FY 2025: -65.1%
FY 2016 5y median -31.3% FY 2025
ROA -57.2%
FY 2016: -319.9%FY 2017: -94.1%FY 2018: -25.6%FY 2019: -42028.7%FY 2020: -27.5%FY 2021: -40.7%FY 2022: -46.4%FY 2023: -122.0%FY 2024: -30.1%FY 2025: -57.2%
FY 2016 5y median -46.4% FY 2025

Growth (YoY)

Revenue 536.8%
FY 2016: 0.0%FY 2017: -66.4%FY 2018: -99.9%FY 2019: -100.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -100.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 536.8%
FY 2016 FY 2025
Operating Income -36.5%
FY 2016: -333.3%FY 2017: 21.8%FY 2018: 99.8%FY 2019: -198943.2%FY 2020: -131.4%FY 2021: -66.3%FY 2022: -12.5%FY 2023: 83.9%FY 2024: 5.1%FY 2025: -36.5%
FY 2016 FY 2025
EPS (diluted) -19.4%
FY 2016: -326.5%FY 2017: 17.2%FY 2018: -108.3%FY 2019: -94.0%FY 2020: -69.1%FY 2021: -43.9%FY 2022: -7.2%FY 2023: 2.4%FY 2024: 85.4%FY 2025: -19.4%
FY 2016 FY 2025
Free Cash Flow 15.1%
FY 2016: -21.2%FY 2017: -231.3%FY 2018: -111.2%FY 2019: -145.8%FY 2020: -52.4%FY 2021: -150.6%FY 2022: 12.3%FY 2023: -39375.3%FY 2024: 48.6%FY 2025: 15.1%
FY 2016 FY 2025

Financial Health

Current Ratio 0.4×
FY 2016: 130×FY 2017: 2.2×FY 2018: 2.0×FY 2019: 1.5×FY 2020: 8.4×FY 2021: 0.0×FY 2022: 4.7×FY 2023: 2.1×FY 2024: 1.0×FY 2025: 0.4×
FY 2016 5y median 1.0× FY 2025
Quick Ratio 0.3×
FY 2016: 129×FY 2017: 2.2×FY 2018: 2.0×FY 2019: 1.5×FY 2020: 8.4×FY 2021: -1.6×FY 2022: 2.8×FY 2023: 2.1×FY 2024: 1.0×FY 2025: 0.3×
FY 2016 5y median 1.0× FY 2025
Debt / Equity 0.5×
FY 2016: 0.0×FY 2017: 12.4×FY 2018: 277×FY 2019: 173×FY 2020: 147×FY 2021: 0.1×FY 2022: 0.2×FY 2023: 0.6×FY 2024: 0.5×FY 2025: 0.5×
FY 2016 5y median 0.5× FY 2025
Net Debt / EBITDA -0.3×
FY 2016: 0.2×FY 2017: -0.7×FY 2018: -0.7×FY 2019: -0.3×FY 2020: -0.6×FY 2021: -0.2×FY 2022: -0.3×FY 2023: 0.2×FY 2024: 0.1×FY 2025: -0.3×
FY 2016 5y median -0.2× FY 2025
Interest Coverage -51.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: -0.0×FY 2019: 0.0×FY 2020: -977×FY 2021: -337×FY 2022: -115×FY 2023: -15.7×FY 2024: -15.6×FY 2025: -51.4×
FY 2016 5y median -51.4× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31